KRTL and AMNI Pharmaceuticals Launch Strategic Distribution Collaboration

KRTL Holding Group, Inc. (“KRTL Holding” or the “Company”) announced today that its wholly owned subsidiary, KRTL Biotech, Inc. (“KRTL Biotech”), has entered into a strategic collaboration with AMNI Pharmaceuticals (“AMNI”), a Texas-based pharmaceutical distribution company, to pursue a supply and distribution initiative beginning in the United States.

Under the collaboration, the parties intend to work toward a commercial framework under which KRTL Biotech would support product supply and AMNI would manage distribution activities through its licensed infrastructure, subject to definitive product-specific agreements and applicable regulatory requirements. The initial focus of the collaboration is to evaluate market opportunities, supply logistics, and channel development relating to methylene blue in the United States.

Cesar Herrera, Chief Executive Officer of KRTL Holding and KRTL Biotech, stated, “This collaboration is intended to align KRTL Biotech’s product supply objectives with AMNI’s distribution capabilities. We believe this structure provides a practical path to evaluate commercial opportunities for methylene blue while maintaining a disciplined approach to compliance, documentation, and execution.”

Fahd Soliman, Chief Executive Officer of AMNI Pharmaceuticals, stated, “We are pleased to begin working with KRTL Biotech on this initiative. Our goal is to assess how the parties can develop an efficient and compliant framework for distribution activities, subject to final agreements and applicable requirements.”

The parties expect to begin with product-specific planning and commercial assessment. Any supply, sale, or distribution would be subject to further documentation, commercial terms, and satisfaction of all applicable operational and regulatory requirements. There can be no assurance that the collaboration will result in completed product sales, distribution activity, or revenue.

KRTL Holding stated that the collaboration is intended to provide a foundation for a defined commercial relationship, while preserving the parties’ separate operational and regulatory responsibilities.

About KRTL Holding Group, Inc.

KRTL Holding Group, Inc. (OTC: KRTL) operates through its subsidiaries KRTL Biotech, Inc. and KRTL International Corp. The Company leverages strategic synergies across biotech, technology, and emerging markets to drive growth and deliver shareholder value.

About KRTL Biotech, Inc.

KRTL Biotech, Inc. focuses on building scalable life-science operations that prioritize quality, compliance, and innovation. The company aims to expand its international footprint while maintaining rigorous U.S. reporting and regulatory standards.

About AMNI Pharmaceuticals

AMNI Pharmaceuticals is a Texas-based company engaged in the licensed distribution of prescription drug products, offering scalable, compliant solutions across healthcare channels ranging from institutional buyers to commercial resellers.

For more information:

www.krtlholding.com | www.krtl-icc.com | www.krtlbiotech.com | www.amnipharmaceuticals.com/

Forward-Looking Statements

This press release contains statements and information that, to the extent that they are not historical fact, may constitute  “forward-looking statements” within the meaning of applicable securities legislation. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. Words such as “anticipates,” “will,” “believes,” “plans,” “expects,” “intends,” “projects,” “estimates,” “future,” and “opportunity” and similar expressions are used to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments and acquisitions; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law.